comparemela.com
Home
Live Updates
Daiichi Sankyo To Transfer Yescarta Marketing Authorization In Japan To Gilead Sciences : comparemela.com
Daiichi Sankyo To Transfer Yescarta Marketing Authorization In Japan To Gilead Sciences
FOSTER CITY (dpa-AFX) - Daiichi Sankyo Co., Ltd. (DSKYF.PK) will transfer yescarta marketing authorization in Japan to Gilead Sciences K.K., the Japan subsidiary of Gilead Sciences Inc. (GILD)
Related Keywords
California ,
United States ,
Japan ,
El Segundo ,
Japanese ,
Daiichi Sankyo ,
Daiichi Sankyo Co Ltd ,
Japan To Gilead Sciences ,
Gilead Sciences ,
Gilead Company ,
Japan Ministry Of Health ,
Gilead Sciences Inc ,
Marketing Authorization ,
Kite Cell Therapy Business Unit ,
Orphan Drug Designation ,
Japan Ministry ,
Daiichi ,
Sankyo ,
Transfer ,
Descarta ,
Marketing ,
Authorization ,
Wilead ,
Ciences ,
comparemela.com © 2020. All Rights Reserved.